S&P 500
7,551.81
-33.92
-0.45%
Dow
51,461.90
-631.21
-1.21%
Nasdaq
25,978.42
-3.15
-0.01%
NYSE Composite
23,934.15
-194.31
-0.81%
Russell 2000
2,858.81
-11.47
-0.40%
VIX
17.71
+0.51
+2.97%
ALHC · Alignment Healthcare, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Alignment Healthcare Inc (ALHC)
NASDAQ NMS - GLOBAL MARKET
Health Care
$8.70
-1.71
(-16.47%)
● At close: September 16 at 4:00:00 PM EDT
$8.75
+0.04
(+0.46%)
Overnight:
9:22:37 PM EDT
DAY'S RANGE
$8.70
$8.52
$10.36
52-WEEK RANGE
$8.70
$9.94
$25.12
What's happening
- ALHC is down 16.47% today, trading at $8.70. — Live quote
- It's trading within 3% of its 52-week low ($9.94). (Finnhub fundamentals)
- Volume today (1,353,643) is well below its 3-month average of 5,997,810. (Finnhub fundamentals)
- Last quarter's EPS beat estimates: $0.17 actual vs. $0.13 estimated (+28.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 8
Buy 9
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-09-01 (20 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ALHC
-47.49%
vs S&P 500
-58.56%
1-YEAR RETURN
ALHC
-36.46%
vs S&P 500
-51.06%
6-MONTH RETURN
ALHC
-42.42%
3-MONTH RETURN
ALHC
-47.49%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.17
Est. $0.13
BEAT +28.8%
2026-04-26 (Q1 2026)
$0.05
Est. $0.01
BEAT +575.7%
2026-01-26 (Q4 2025)
$-0.05
Est. $-0.16
BEAT +67.9%
2025-10-26 (Q3 2025)
$0.02
Est. $-0.08
BEAT +124.2%
Valuation Measures & Ratios
Enterprise Value4$2.31B
Forward P/E557.66
PEG Ratio6—
Price / Sales (TTM1)0.59
Price / Book718.57
EV4 / Revenue0.51
EV4 / EBITDA26.76
Profit Margin0.89%
Operating Margin1.20%
Return on Equity (ROE8)20.02%
Return on Assets (ROA9)3.46%
Avg Volume (3M)5,997,810
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $5.12B | $4.03B | $3.26B | $3.13B | $3.39B |
| P/E | 76.05 | 185.51 | -201.93 | -71.40 | -32.00 |
| Price/Sales | 1.12 | 0.97 | 0.90 | 0.94 | 1.16 |
| Price/Book | 19.33 | 19.46 | 20.12 | 22.22 | 31.39 |
| EV/Revenue | 1.04 | 0.87 | 0.82 | 0.90 | 1.12 |
| EV/EBITDA | 40.05 | 51.35 | 82.90 | — | — |
| ROE | 25.41% | 10.49% | -9.97% | -31.12% | -98.08% |
| ROA | 5.27% | 1.72% | -1.46% | -4.39% | -11.84% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short22,837,600
Change from Prior Settlement-2.96%
% of Float—
Days to Cover (Short Ratio)6.04
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-31. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 31.6% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-16; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 0.9%. Finnhub fundamentals ↗
- Trailing 52-week price return is -36.5%. Finnhub market metrics ↗
- Trailing P/E is 66.0, a high price relative to reported earnings. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ALHC
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.34B | $1.24B | $993.7M | $1.02B | $926.9M | $692.4M | $681.3M | $628.6M |
| Operating income | $42.1M | $15.5M | $7.7M | $22.7M | -$5.4M | -$19.5M | -$18.4M | -$41.1M |
| Net income | $36.6M | $11.4M | $3.7M | $15.7M | -$9.1M | -$26.4M | -$24.0M | -$46.5M |
| EPS (diluted) | $0.17 | $0.05 | $0.02 | $0.07 | $-0.05 | $-0.14 | $-0.13 | $-0.25 |
| EPS (basic) | $0.18 | $0.06 | $0.02 | $0.08 | $-0.05 | $-0.14 | $-0.13 | $-0.25 |
| Operating margin | $3 | $1 | $1 | $2 | -$1 | -$3 | -$3 | -$7 |
| Net margin | $3 | $1 | $0 | $2 | -$1 | -$4 | -$4 | -$7 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.28B | $1.26B | $1.07B | $1.10B | $1.00B | $895.6M | $782.1M | $692.3M |
| Total liabilities | $1.01B | $1.05B | $886.5M | $940.7M | $859.2M | $786.6M | $681.1M | $576.7M |
| Stockholders' equity | $265.1M | $206.9M | $179.3M | $161.9M | $141.0M | $108.1M | $99.9M | $114.5M |
| Total current assets | $1.16B | $1.15B | $951.6M | $985.3M | $880.1M | $774.5M | $661.6M | $573.6M |
| Total current liabilities | $683.4M | $724.8M | $556.9M | $611.1M | $529.5M | $457.1M | $351.8M | $358.1M |
| Cash & equivalents | $693.5M | $705.6M | $575.8M | $618.1M | $470.3M | $446.2M | $432.9M | $340.3M |
| Marketable securities (current) | $8.3M | $20.7M | $28.4M | $26.0M | $33.5M | $33.4M | $37.8M | $40.7M |
| Accounts receivable | $296.9M | $277.7M | $253.2M | $219.8M | $282.9M | $214.1M | $153.9M | $138.9M |
| Property, plant & equipment | $66.2M | $63.9M | $64.3M | $67.0M | $69.5M | $68.5M | $67.1M | $64.7M |
| Goodwill | $32.1M | $32.1M | $32.1M | $32.1M | $32.1M | $34.2M | $34.8M | $34.8M |
| Intangible assets | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M |
| Other non-current assets | $8.5M | $8.7M | $6.3M | $6.3M | $6.3M | $6.1M | $6.1M | $6.5M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.6M |
| Long-term debt | $324.1M | $323.6M | $323.2M | $322.7M | $322.3M | $321.9M | $321.4M | $210.4M |
| Common stock & paid-in capital | $207.0K | $207.0K | $205.0K | $200.0K | $198.0K | $198.0K | $192.0K | $191.0K |
| Retained earnings | -$961.0M | -$997.6M | -$1.01B | -$998.0M | -$1.00B | -$1.02B | -$1.01B | -$977.2M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$17.3M | $128.7M | -$50.4M | $144.6M | $29.1M | $16.6M | -$8.7M | $26.2M |
| Investing cash flow | $2.4M | $578.0K | -$7.2M | $2.3M | -$6.7M | -$3.5M | -$5.9M | -$24.6M |
| Financing cash flow | $2.8M | $515.0K | $15.3M | $948.0K | $1.6M | $181.0K | $106.9M | $0 |
| Free cash flow | -$27.5M | $121.3M | -$55.4M | $139.1M | $21.1M | $8.4M | -$18.0M | $16.9M |
| Capital expenditures | $10.1M | $7.4M | $5.0M | $5.5M | $8.0M | $8.3M | $9.3M | $9.3M |
| Depreciation & amortization | $7.9M | $7.8M | $22.8M | $8.0M | $7.0M | $7.6M | $20.9M | $7.6M |
| Share-based compensation | $18.2M | $14.0M | $13.1M | $16.2M | $15.6M | $17.2M | $16.2M | $17.3M |
| Change in accounts receivable | $19.5M | $24.5M | $33.7M | -$62.8M | $69.1M | $60.2M | $15.1M | -$44.3M |
| Purchases of investments | $6.2M | $10.6M | $20.4M | $10.2M | $17.1M | $17.9M | $6.7M | $35.5M |
| Debt issued | — | — | $0 | $0 | $0 | — | $330.0M | $0 |
| Debt repaid | — | — | $0 | — | — | — | $215.0M | — |
| Tax withholding on stock comp | — | — | $0 | $0 | $0 | $0 | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $3.95B | $2.70B | $1.82B | $1.43B | $1.17B |
| Operating income | $14.8M | -$101.6M | -$127.8M | -$128.6M | -$178.1M |
| Net income | -$724.0K | -$128.0M | -$148.0M | -$149.5M | -$195.3M |
| EPS (diluted) | $0.00 | $-0.67 | $-0.79 | $-0.83 | $-1.14 |
| EPS (basic) | $0.00 | $-0.67 | $-0.79 | $-0.83 | $-1.14 |
| Operating margin | $0 | -$4 | -$7 | -$9 | -$15 |
| Net margin | -$0 | -$5 | -$8 | -$10 | -$17 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.07B | $782.1M | $591.9M | $633.9M | $630.9M |
| Total liabilities | $886.5M | $681.1M | $433.8M | $394.6M | $324.8M |
| Stockholders' equity | $179.3M | $99.9M | $156.9M | $238.1M | $306.0M |
| Total current assets | $951.6M | $661.6M | $483.5M | $544.5M | $552.9M |
| Total current liabilities | $556.9M | $351.8M | $263.0M | $230.0M | $167.2M |
| Cash & equivalents | $575.8M | $432.9M | $202.9M | $409.5M | $466.6M |
| Marketable securities (current) | $28.4M | $37.8M | $115.9M | $0 | — |
| Accounts receivable | $253.2M | $153.9M | $119.7M | $92.9M | $58.5M |
| Property, plant & equipment | $64.3M | $67.1M | $51.9M | $37.2M | $30.4M |
| Goodwill | $32.1M | $34.8M | $34.8M | $34.8M | $29.3M |
| Intangible assets | $4.5M | $4.5M | $5.3M | $5.5M | — |
| Other non-current assets | $6.3M | $6.1M | $6.4M | $6.0M | $4.7M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 |
| Long-term debt | $323.2M | $321.4M | $161.8M | $160.9M | $150.6M |
| Common stock & paid-in capital | $205.0K | $192.0K | $189.0K | $187.0K | $187.0K |
| Retained earnings | -$1.01B | -$1.01B | -$880.3M | -$732.2M | -$582.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $139.9M | $34.8M | -$59.2M | -$45.4M | -$78.8M |
| Investing cash flow | -$15.0M | $39.2M | -$147.3M | -$28.2M | -$20.8M |
| Financing cash flow | $18.0M | $156.0M | $105.0K | $16.6M | $360.1M |
| Free cash flow | $113.1M | -$6.6M | -$95.2M | -$69.2M | — |
| Capital expenditures | $26.8M | $41.4M | $36.0M | $23.8M | — |
| Depreciation & amortization | $30.4M | $26.9M | $21.4M | $17.3M | $15.8M |
| Share-based compensation | $62.1M | $71.1M | $66.8M | $81.7M | $621.0K |
| Change in accounts receivable | $100.1M | $34.3M | $26.9M | $34.4M | $17.6M |
| Purchases of investments | $65.6M | $82.2M | $379.1M | $2.8M | $2.5M |
| Debt issued | $0 | $380.0M | $0 | $165.0M | $0 |
| Debt repaid | $0 | $215.0M | $0 | $143.2M | $0 |
| Tax withholding on stock comp | $0 | $350.0K | $0 | $0 | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ALHC as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Set BUSINESSQUANT_API_KEY to enable institutional ownership.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-23 to 2026-09-11
Recent transactions
- Insiders have net sold 2,960,861 shares over the last 182 days, across 1 purchase and 28 sales.
- Most recent: Maroney Dawn Christine (President) — Open market sale of 122,707 shares on 2026-09-11.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)14,848 sh(1 txns)
Sales (open market)2,975,709 sh(28 txns)
Net Shares-2,960,861
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Maroney Dawn Christine | President | Open market sale | 2026-09-11 | 122,707 |
| KAO JOHN E | Chief Executive Officer | Open market sale | 2026-09-11 | 385,270 |
| Hochradel Shane J. | Chief Operations Officer | Grant / award | 2026-07-01 | 87,719 |
| KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Open market sale | 2026-07-01 | 25,000 |
| Kim Hyong | Chief Medical Officer | Open market sale | 2026-06-12 | 35,951 |
| Kent Mark D. | President - MSO | Grant / award | 2026-06-03 | 87,719 |
| Head James M | Chief Financial Officer | Open market sale | 2026-04-07 | 11,100 |
| JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Open market sale | 2026-04-01 | 18,013 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-11 | Maroney Dawn Christine | President | Open market sale | 122,707 | $12.68 |
| 2026-09-11 | KAO JOHN E | Chief Executive Officer | Open market sale | 385,270 | $12.68 |
| 2026-09-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 172,600 | $12.96 |
| 2026-08-14 | Maroney Dawn Christine | President | Open market sale | 5,000 | $14.00 |
| 2026-08-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 298,000 | $13.88 |
| 2026-07-15 | Maroney Dawn Christine | President | Option exercise | 152,068 | $9.06 |
| 2026-07-15 | Maroney Dawn Christine | President | Open market sale | 177,068 | $20.83 |
| 2026-07-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 279,644 | $19.81 |
| 2026-07-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 18,356 | $20.65 |
| 2026-07-01 | Hochradel Shane J. | Chief Operations Officer | Grant / award | 87,719 | $0.00 |
| 2026-07-01 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Open market sale | 25,000 | $24.00 |
| 2026-06-26 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Open market sale | 25,000 | $23.00 |
| 2026-06-18 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Open market sale | 25,000 | $22.00 |
| 2026-06-15 | Maroney Dawn Christine | President | Open market sale | 30,000 | $19.55 |
| 2026-06-12 | Kim Hyong | Chief Medical Officer | Open market sale | 35,951 | $19.86 |
| 2026-06-11 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Open market sale | 25,000 | $21.00 |
| 2026-06-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 74,936 | $19.65 |
| 2026-06-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 223,064 | $20.60 |
| 2026-06-03 | Kent Mark D. | President - MSO | Grant / award | 87,719 | $0.00 |
| 2026-06-03 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Grant / award | 122,807 | $0.00 |
| 2026-06-02 | Kent Mark D. | President - MSO | Open market purchase | 14,848 | $13.31 |
| 2026-05-18 | Maroney Dawn Christine | President | Gift | 20,000 | $0.00 |
| 2026-05-15 | Maroney Dawn Christine | President | Open market sale | 30,000 | $16.09 |
| 2026-05-15 | Maroney Dawn Christine | President | Gift | 1,500 | $0.00 |
| 2026-05-11 | KAO JOHN E | Chief Executive Officer | Open market sale | 280,893 | $16.85 |
| 2026-05-11 | KAO JOHN E | Chief Executive Officer | Open market sale | 17,107 | $17.54 |
| 2026-04-15 | Maroney Dawn Christine | President | Open market sale | 30,000 | $20.87 |
| 2026-04-13 | KAO JOHN E | Chief Executive Officer | Open market sale | 82,299 | $20.80 |
| 2026-04-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 201,900 | $20.58 |
| 2026-04-10 | KAO JOHN E | Chief Executive Officer | Open market sale | 13,801 | $21.38 |
| 2026-04-07 | Head James M | Chief Financial Officer | Open market sale | 11,100 | $21.08 |
| 2026-04-07 | KAO JOHN E | Chief Executive Officer | Open market sale | 132,241 | $20.67 |
| 2026-04-07 | KAO JOHN E | Chief Executive Officer | Open market sale | 117,759 | $21.40 |
| 2026-04-01 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Open market sale | 18,013 | $17.79 |
| 2026-03-23 | KAO JOHN E | Chief Executive Officer | Open market sale | 118,000 | $17.48 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-17 01:34 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-11 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-10 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-07-30 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-30 | 8-K | 2026-07-30 | View on SEC.gov → |
| 2026-07-16 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-14 | 4 | 2026-07-10 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-26 | View on SEC.gov → |
Recent news
Headlines about ALHC (Alignment Healthcare, Inc.). Links open the publisher — we don’t host full articles.
-
Alignment healthcare CEO John Kao sells $356,200 in ALHC stock
Investing.com India · 2026-09-16 -
Alignment Healthcare (NASDAQ: ALHC) director plans tax-cover sale of 26,000 shares
Stock Titan · 2026-09-16 -
ALHC ALERT: Hagens Berman Updates Investigation of
GlobeNewswire · 2026-09-16 -
Alignment Healthcare (ALHC) Faces Medicare Advantage Reform, Is It A Bargain?
Yahoo Finance · 2026-09-16 -
Alignment Healthcare extends retreat, falls an additional 16%
Seeking Alpha · 2026-09-16 -
Alignment Healthcare extends retreat, falls an additional 16% (ALHC:NASDAQ)
Seeking Alpha · 2026-09-16 -
Is Alignment Healthcare (ALHC) A Bargain After Medicare Advantage Reform Fears?
simplywall.st · 2026-09-16 -
How Could Alignment Healthcare (ALHC) Handle New Medicare Advantage Rule Changes?
Yahoo Finance · 2026-09-16
No headlines in this category right now — try “All”.